激酶
药物治疗
生物化学
乙酰转移酶
临床生物化学
药理学
化学
生物
计算生物学
生物信息学
医学
内科学
乙酰化
基因
作者
Xinnan Zhang,Jie Zhang,Xinze Li,Feng Qiu,Qiang Zhang,Ning Kang
标识
DOI:10.1016/j.bcp.2025.117207
摘要
Pantothenate kinases (PANKs), which regulate the first and rate-limiting step of coenzyme A (CoA) biosynthesis, have emerged as therapeutic targets for various human diseases. PANKs family consists of PANK1, PANK2, PANK3, and PANK4. We summarized the research progress of the PANK family in the last two decades. Notably, PANKs play critical roles in diverse pathophysiological mechanisms underlying human diseases, including pantothenate kinase-associated neurodegeneration (PKAN), propionic acidemia (PA), lipid metabolic disorders, Parkinson's disease (PD), glioma, clear cell renal cell carcinoma (ccRCC), and insulin resistance (IR). Nevertheless, the precise relationship between PANKs and human diseases remained ambiguous. Therefore, this review provides a comprehensive summary of the structural properties, molecular mechanisms, and relevant modulators that govern PANK activity. In conclusion, targeting PANKs as regulators of CoA biosynthesis and disease pathogenesis contributes to connecting biochemistry with pharmacotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI